AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇹🇳

TÉMOZOLOMIDE in Tunisia

11 products registered with DPM 0 active, 11 expired

Brand / ProductReg. No.HolderStatusExpires
TEMOZOLOMIDE NEAPOLIS
Gélule / 100 mg
9393243HNEAPOLIS PHARMAexpired9 Sept 2022
TEMOZOLOMIDE NEAPOLIS
Gélule / 250 mg
9393244HNEAPOLIS PHARMAexpired9 Sept 2022
TEMOZOLOMIDE NEAPOLIS
Gélule / 20 mg
9393242HNEAPOLIS PHARMAexpired9 Sept 2022
TEMO
Gélule / 20 mg
9453012HLINO PHARMAexpired14 Sept 2021
TEMO
Gélule / 5 mg
9453011HLINO PHARMAexpired14 Sept 2021
TEMO
Gélule / 250 mg
9453014HLINO PHARMAexpired14 Sept 2021
TEMO
Gélule / 100 mg
9453013HLINO PHARMAexpired14 Sept 2021
TEGOZOL
Gélule / 20 mg
6653672HIKMA Pharmaceuticalsexpired16 Mar 2020
TEGOZOL
Gélule / 5 mg
6653673HIKMA Pharmaceuticalsexpired16 Mar 2020
TEGOZOL
Gélule / 100 mg
6653674HIKMA Pharmaceuticalsexpired16 Mar 2020
TEGOZOL
Gélule / 250 mg
6553671HIKMA Pharmaceuticalsexpired6 Apr 2017

TÉMOZOLOMIDEDPM Registration Details

DPM (Tunisia) has 11 registered products containing TÉMOZOLOMIDE, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.

Track TÉMOZOLOMIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

T Mozolomide — Tunisia (DPM) | AfricaRegulatory